Cargando…
Shaping the future from the small scale: dry powder inhalation of CRISPR-Cas9 lipid nanoparticles for the treatment of lung diseases
INTRODUCTION: Most lung diseases are serious conditions resulting from genetic and environmental causes associated with high mortality and severe symptoms. Currently, treatments available have a palliative effect and many targets are still considered undruggable. Gene therapy stands as an attractive...
Autores principales: | Carneiro, Simone P., Greco, Antonietta, Chiesa, Enrica, Genta, Ida, Merkel, Olivia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614984/ https://www.ncbi.nlm.nih.gov/pubmed/36896650 http://dx.doi.org/10.1080/17425247.2023.2185220 |
Ejemplares similares
-
Hyaluronic Acid-Based Nanoparticles for Protein Delivery: Systematic Examination of Microfluidic Production Conditions
por: Chiesa, Enrica, et al.
Publicado: (2021) -
CD44-Targeted Carriers: The Role of Molecular Weight of Hyaluronic Acid in the Uptake of Hyaluronic Acid-Based Nanoparticles
por: Chiesa, Enrica, et al.
Publicado: (2022) -
Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery
por: Zimmermann, Christoph M, et al.
Publicado: (2022) -
Simultaneous Spray Drying for Combination Dry Powder Inhaler Formulations
por: Shepard, Kimberly B., et al.
Publicado: (2022) -
Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)